HIGHLIGHTS
en Cáncer de Colon

ASCO COLON 2020

Highlights comentados por:
Dra. Encarna González Flores
Oncóloga en el Hospital Universitario Virgen de las Nieves de Granada.
Optimizando el tratamiento adyuvante del cáncer de colon (CC).
17 de junio de 2020

Optimizando el tratamiento adyuvante del cáncer de colon (CC).

4003. Aspirin and cyclooxygenase-2 (COX-2) inhibitors have been associated with a reduced risk of colorectal polyps and cancer in observational and randomized studies. CALGB/SWOG 80702 tested the effect of celecoxib, a COX-2 inhibitor, on reducing the risk of recurrence in stage III CC. Jeffrey A. Meyerhardt et al